Adial pharmaceuticals receives notice of exercise from adovate for the acquisition of purnovate's assets and business

Adial to receive potential development and commercial milestone payments of up to $83 million on the first three compounds plus 19.9% equity stake and ongoing royalties adial to receive potential development and commercial milestone payments of up to $83 million on the first three compounds plus 19.9% equity stake and ongoing royalties
ADIL Ratings Summary
ADIL Quant Ranking